Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IMRAN S NATHANI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1164495339
CMS profile
143206
Location
TOMBALL, TX

General Payments · PY2018–2024

$10,050.09

  • Reported across 169 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$272.41

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $272.41 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Biosense Webster, Inc. $67.90 1
Acerta Pharma LLC $64.35 4
DEXCOM, INC. $36.67 2
Amgen Inc. $36.65 2
Abbott Laboratories $20.25 1
Lilly USA, LLC $17.27 1
Exact Sciences Corporation $15.42 1
Otsuka America Pharmaceutical, Inc. $13.90 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,302.71 14
PY2019 $2,209.45 18
PY2020 $501.61 28
PY2021 $2,984.48 56
PY2022 $510.61 26
PY2023 $268.82 14
PY2024 $272.41 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.25 11/07/2024 Food and Beverage Undisputed 01/23/2026 1124877090 CMS
Amgen Inc. $18.42 05/23/2024 Food and Beverage Undisputed 01/23/2026 1117337049 CMS
Amgen Inc. $18.23 11/15/2024 Food and Beverage Undisputed 01/23/2026 1111660303 CMS
AstraZeneca Pharmaceuticals LP $16.19 04/05/2024 Food and Beverage Undisputed 01/23/2026 1104426551 CMS
AstraZeneca Pharmaceuticals LP $16.00 08/16/2024 Food and Beverage Undisputed 01/23/2026 1105322916 CMS
AstraZeneca Pharmaceuticals LP $18.64 10/18/2024 Food and Beverage Undisputed 01/23/2026 1105860488 CMS
AstraZeneca Pharmaceuticals LP $13.52 11/01/2024 Food and Beverage Undisputed 01/23/2026 1104372181 CMS
Biosense Webster, Inc. $67.90 03/21/2024 Food and Beverage Undisputed 01/23/2026 1077737277 CMS
Dexcom, Inc. $21.17 05/31/2024 Food and Beverage Undisputed 01/23/2026 1153304549 CMS
Dexcom, Inc. $15.50 11/19/2024 Food and Beverage Undisputed 01/23/2026 1153304551 CMS
Exact Sciences Corporation $15.42 08/23/2024 Food and Beverage Undisputed 01/23/2026 1114805513 CMS
Lilly USA, LLC $17.27 04/20/2024 Food and Beverage Undisputed 01/23/2026 1135033694 CMS
Otsuka America Pharmaceutical, Inc. $13.90 03/08/2024 Food and Beverage Undisputed 01/23/2026 1118949214 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.